In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9

Swiech, Lukasz, Heidenreich, Matthias, Banerjee, Abhishek, Habib, Naomi, Li, Yinqing, Trombetta, John, Sur, Mriganka, Zhang, Feng·2015·Nature Biotechnology
DOI 10.1038/nbt.3055

Cited by (771)

Items 201–300 of 771

  1. From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine
    Weihui Xu, Shiyao Zhang, Huan Qin, Kai Yao · 2024 · Journal of Translational Medicine
  2. Strategies for precision modulation of gene expression by epigenome editing: an overview
    Benjamin I. Laufer, Shiva M. Singh · 2015 · Epigenetics & Chromatin
  3. The Development of a Viral Mediated CRISPR/Cas9 System with Doxycycline Dependent gRNA Expression for Inducible In vitro and In vivo Genome Editing
    Christopher A. de Solis, Anthony Ho, Roopashri Holehonnur, Jonathan E. Ploski · 2016 · Frontiers in Molecular Neuroscience
  4. Creating cell and animal models of human disease by genome editing using CRISPR/Cas9
    Ali Zarei, Vahid Razban, Seyed Ebrahim Hosseini, Kaoru Tabei · 2019 · The Journal of Gene Medicine
  5. Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome
    Luoni, Mirko, Giannelli, Serena, Indrigo, Marzia Tina, Niro, Antonio, Massimino, Luca, Iannielli, Angelo, Passeri, Laura, Russo, Fabio, Morabito, Giuseppe, Calamita, Piera et al. · 2020 · eLife
  6. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment
    Edward M. Kennedy, Bryan R. Cullen · 2015 · Virology
  7. CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
    Mujeeb Ur Rahman, Muhammad Bilal, Junaid Ali Shah, Ajeet Kumar Kaushik, Pierre‐Louis Teissèdre, Małgorzata Kujawska · 2022 · Pharmaceutics
  8. Designed nucleases for targeted genome editing
    Junwon Lee, Jae‐Hee Chung, Ho Min Kim, Seokjoong Kim, Seokjoong Kim · 2015 · Plant Biotechnology Journal
  9. Fluorescent protein tagging of endogenous protein in brain neurons using CRISPR/Cas9-mediated knock-in and in utero electroporation techniques
    Takeshi Uemura, Takuma Mori, Taiga Kurihara, Shiori Kawase, Rie Koike, Michiru Satoga, Xueshan Cao, Xue Li, Toru Yanagawa, Takayuki Sakurai et al. · 2016 · Scientific Reports
  10. CRISPR–Cas9-mediated genome editing and guide RNA design
    Michael V. Wiles, Wenning Qin, Albert W. Cheng, Haoyi Wang · 2015 · Mammalian Genome
  11. Update of neurotrophic factors in neurobiology of addiction and future directions
    Maryna Koskela, Susanne Bäck, Vootele Võikar, Christopher T. Richie, Andrii Domanskyi, Brandon K. Harvey, Mikko Airavaara · 2016 · Neurobiology of Disease
  12. The era of gene therapy: From preclinical development to clinical application
    Nabil A. Alhakamy, David T. Curiel, Cory J. Berkland · 2021 · Drug Discovery Today
  13. Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9
    Kshitiz Singh, Hanneke Evens, Nisha Nair, Melvin Y. Rincón, Shilpita Sarcar, Ermira Samara-Kuko, Marinee Chuah, Thierry VandenDriessche · 2018 · Molecular Therapy
  14. CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review
    Nirmal Chandra Barman, Md. Niuz Morshed Khan, Maidul Islam, Zulkar Nain, Rajib Kanti Roy, Anwarul Haque, Shital Kumar BARMAN · 2020 · Neurology and Therapy
  15. In vivo outer hair cell gene editing ameliorates progressive hearing loss in dominant-negative Kcnq4 murine model
    Byunghwa Noh, John Hoon Rim, Ramu Gopalappa, Haiyue Lin, Kyu Min Kim, Min Jin Kang, Heon Yung Gee, Jae Young Choi, Seokjoong Kim, Jinsei Jung · 2022 · Theranostics
  16. Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation
    Xionggao Huang, Guohong Zhou, Wenyi Wu, Gaoen Ma, Patrìcia A. D'Amore, Shizuo Mukai, Hetian Lei · 2017 · Investigative Ophthalmology & Visual Science
  17. MANF regulates hypothalamic control of food intake and body weight
    Su Yang, Huiming Yang, Renbao Chang, Peng Yin, Yang Yang, Weili Yang, Shanshan Huang, Marta A. Gaertig, Shihua Li, Xiao‐Jiang Li · 2017 · Nature Communications
  18. CRISPR-delivery particles targeting nuclear receptor–interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure
    Yuefei Shen, Jessica L. Cohen, Sarah M. C. Nicoloro, Mark Kelly, Batuhan Yenilmez, Felipe dos Santos Henriques, Emmanouela Tsagkaraki, Yvonne J. K. Edwards, Xiaodi Hu, Randall H. Friedline et al. · 2018 · Journal of Biological Chemistry
  19. Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9‐Mediated Knockin of Retinoschisin 1 Gene—A Potential Nonviral Therapeutic Solution for X‐Linked Juvenile Retinoschisis
    Shih‐Jie Chou, Peng Yang, Qian Ban, Yi Ping Yang, Mong‐Lien Wang, Chian‐Shiu Chien, Shih Jen Chen, Na Sun, Yazhen Zhu, Hongtao Liu et al. · 2020 · Advanced Science
  20. Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
    Li, Hao, Sheng, Chunyu, Liu, Hongbo, Wang, Shan, Zhao, Jiangyun, Yang, Lang, Jia, Leili, Li, Peng, Wang, Ligui, Xie, Jing et al. · 2018 · Frontiers in Immunology
  21. CRISPR/Cas9 and cancer targets: future possibilities and present challenges
    Martyn K. White, Kamel Khalili · 2016 · Oncotarget
  22. Vasoactive intestinal peptide controls the suprachiasmatic circadian clock network via ERK1/2 and DUSP4 signalling
    Ryan Hamnett, Priya Crosby, Johanna Elizabeth Chesham, Michael Harvey Hastings · 2019 · Nature Communications
  23. The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
    Jingyi Wang, Chenzi Zhang, Bo Feng · 2020 · Journal of Cellular and Molecular Medicine
  24. Reversal of Social Recognition Deficit in Adult Mice with MECP2 Duplication via Normalization of MeCP2 in the Medial Prefrontal Cortex
    Yu, Bin, Yuan, Bo, Dai, Jian-Kun, Cheng, Tian-lin, Xia, Sheng-Nan, He, Ling-Jie, Yuan, Yi-Ting, Zhang, Yue-Fang, Xu, Hua-Tai, Xu, Fu-Qiang et al. · 2020 · Neuroscience Bulletin
  25. Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals
    Kuchuan Chen, Tammy Szu‐Yu Ho, Guang Lin, Kai Li Tan, Matthew Neil Rasband, Hugo Jozef Bellen · 2016 · eLife
  26. Progress and challenges towards CRISPR/Cas clinical translation
    Daniel Rosenblum, Anna Gutkin, Niels Dammes, Dan Peer · 2020 · Advanced Drug Delivery Reviews
  27. In Utero Cortical Electroporation of Plasmids in the Mouse Embryo
    Géraldine Meyer-Dilhet, Julien Courchet · 2020 · STAR Protocols
  28. Approaches and materials for endocytosis-independent intracellular delivery of proteins
    Nanxi Chen, Ye He, Mingming Zang, Youxi Zhang, Hong‐Yan Lü, Qinfu Zhao, Siling Wang, Yikun Gao · 2022 · Biomaterials
  29. Calcium signaling in neocortical development
    Per Uhlén, Nicolas Fritz, Erik Smedler, Seth Malmersjö, Shigeaki Kanatani · 2015 · Developmental Neurobiology
  30. Xeroderma Pigmentosum – Facts and Perspectives
    Janin Lehmann, Christina Seebode, Marie Christine Martens, Steffen Emmert · 2018 · Anticancer Research
  31. CRISPR/Cas9 cleavage efficiency regression through boosting algorithms and Markov sequence profiling
    Hui Peng, Yi Zheng, Michael Blumenstein, Dacheng Tao, Jinyan Li · 2018 · Bioinformatics
  32. CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
    Weili Yang, Zhuchi Tu, Qiang Sun, Xiao‐Jiang Li · 2016 · Frontiers in Molecular Neuroscience
  33. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
    Nivya Kolli, Ming Lü, Panchanan Maiti, Julien Rossignol, Gary Leo Dunbar · 2017 · Neurochemistry International
  34. Porcine genome engineering for xenotransplantation
    Dong Niu, Xiang Ma, Taoyan Yuan, Yifan Niu, Yibin Xu, Zhongxin Sun, Ping Yuan, Weifen Li, Jufang Zhang, Tao Wang et al. · 2020 · Advanced Drug Delivery Reviews
  35. Genome editing for inborn errors of metabolism: advancing towards the clinic
    Jessica L. Schneller, Ciaran M. Lee, Gang Bao, Charles P. Venditti · 2017 · BMC Medicine
  36. TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus
    Bingjie Shi, Juan Li, Xuanling Shi, Wenxu Jia, Yi Wen, Xiongbing Hu, Fengfeng Zhuang, Jianzhong Xi, Linqi Zhang · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  37. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field
    Zhiyao He, Ke Men, Zhou Qin, Yang Yang, Ting Xu, Yu-Quan Wei · 2017 · Science China Life Sciences
  38. Recognition of CRISPR/Cas9 off‐target sites through ensemble learning of uneven mismatch distributions
    Hui Peng, Yi Zheng, Zhixun Zhao, Tao Liu, Jinyan Li · 2018 · Bioinform.
  39. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice
    Qiaoqiao Xiao, Shuliang Chen, Qiankun Wang, Zhepeng Liu, Shuai Liu, Huan Deng, Wei Hou, Dongcheng Wu, Yong Xiong, Jiafu Li et al. · 2019 · Retrovirology
  40. Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
    Yu-Fan Chuang, Andrew J. Phipps, Fan‐Li Lin, Valerie F G Hecht, Alex William Hewitt, Peng‐Yuan Wang, Guei‐Sheung Liu · 2021 · Cellular and Molecular Life Sciences
  41. Moving from in vitro to in vivo CRISPR screens
    Maria Kuhn, António J. Santinha, Randall J. Platt · 2021 · Gene and Genome Editing
  42. Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brain
    Bryan P. Simpson, Carolyn M. Yrigollen, Aleksandar Izda, Beverly L. Davidson · 2023 · Molecular Therapy
  43. Review: Recent Applications of Gene Editing in Fish Species and Aquatic Medicine
    Anikó Gutási, Sabine Elisabeth Hammer, Mansour El‐Matbouli, Mona Saleh · 2023 · Animals
  44. A human brain vascular atlas reveals diverse cell mediators of Alzheimer’s disease risk
    Yang, Andrew C., Vest, Ryan T., Kern, Fabian, Lee, Davis P., Maat, Christina A., Losada, Patricia M., Chen, Michelle B., Agam, Maayan, Schaum, Nicholas, Khoury, Nathalie et al. · 2021
  45. Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
    Vo Van Giau, Hyon Lee, Kyu Hwan Shim, Eva Bagyinszky, Seong Soo A. An · 2018 · Clinical Interventions in Aging
  46. A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges
    Hafiz Ishfaq Ahmad, Muhammad Jamil Ahmad, Akhtar Rasool Asif, Muhammad Adnan, Muhammad Kashif Iqbal, Khalid Mehmood, Sayyed Aun Muhammad, Ali Akbar Bhuiyan, Abdelmotaleb Elokil, Xiaoyong Du et al. · 2018 · Current Issues in Molecular Biology
  47. In Vivo Editing of Macrophages through Systemic Delivery of CRISPR‐Cas9‐Ribonucleoprotein‐Nanoparticle Nanoassemblies
    Yi‐Wei Lee, Rubul Mout, David C. Luther, Yuanchang Liu, Laura J. Castellanos-García, Amy Burnside, Moumita Ray, Gülen Yesilbag Tonga, Joseph Michael Hardie, Harini Nagaraj et al. · 2019 · Advanced Therapeutics
  48. In vivo epigenome editing and transcriptional modulation using CRISPR technology
    Cia‐Hin Lau, Yousin Suh · 2018 · Transgenic Research
  49. Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond
    Paul N. Valdmanis, Mark A. Kay · 2017 · Human Gene Therapy
  50. Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards Separating Facts and Fiction.
    Adam P. Cribbs, Sumeth Perera · 2017 · PubMed Central
  51. CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
    Stella Baliou, Maria Adamaki, Anthony M. Kyriakopoulos, Demetrios A. Spandidos, Mihalis I. Panayiotidis, Ioannis Christodoulou, Vassilis C. Zoumpourlis · 2018 · International Journal of Oncology
  52. Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia
    Dennis Kätzel, Amy R. Wolff, Alexei M. Bygrave, David M. Bannerman · 2020 · Frontiers in Pharmacology
  53. Education and the Environment: Learning To Live with Limits.
    Gregory A. Smith · 1992
  54. CRISPR-Cas9-mediated genome editing in one blastomere of two-cell embryos reveals a novel Tet3 function in regulating neocortical development
    Lingbo Wang, Min-Yin Li, Chao Qu, Wanying Miao, Qi Yin, Jiaoyang Liao, Hua-Teng Cao, Min Huang, Kai Wang, Erwei Zuo et al. · 2017 · Cell Research
  55. Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9
    Alvin H.K. Cheung, Chit Chow, Jinglin Zhang, Yuhang Zhou, Tingting Huang, Kayla Ching-Kei Ng, Terry C. T. Or, Yoyo Yao Yao, Yujuan Dong, Jackie Mei-Wah Fung et al. · 2018 · Laboratory Investigation
  56. Editing the Central Nervous System Through CRISPR/Cas9 Systems
    Agustín Cota-Coronado, Néstor Fabián Díaz-Martínez, Eduardo Padilla‐Camberos, Nestor Emmanuel Diaz-Martinez · 2019 · Frontiers in Molecular Neuroscience
  57. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease
    Sandy S. C. Hung, Tristan McCaughey, Olivia G. Swann, Alice Pébay, Alex William Hewitt · 2016 · Progress in Retinal and Eye Research
  58. Gene therapy and editing: Novel potential treatments for neuronal channelopathies
    Robert C. Wykes, Gabriele Lignani · 2017 · Neuropharmacology
  59. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells
    Sanne Hindriksen, Arne J. Bramer, My Anh Truong, Martijn J.M. Vromans, Jasmin B. Post, Ingrid Verlaan-Klink, Hugo J.G. Snippert, Susanne M. A. Lens, Michael A. Hadders · 2017 · PLoS ONE
  60. CRISPR in Animals and Animal Models
    Ellen L. Shrock, Marc Güell · 2017 · Progress in molecular biology and translational science
  61. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
    Gulzar Ahmad, Mansoor M. Amiji · 2018 · Drug Discovery Today
  62. CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
    Bilal Ahmad Lone, Shibendra Kumar Lal Karna, Faiz Ahmad, Nerina Shahi, Yuba Raj Pokharel · 2018 · Genetics Research International
  63. The current and emerging therapeutic approaches in drug-resistant epilepsy management
    Amir Mehdizadeh, Mohammad Barzegar, Sohrab Negargar, Azita Yahyavi, Sina Raeisi · 2019 · Acta Neurologica Belgica
  64. Quantitative Rodent Brain Receptor Imaging
    Kristina Herfert, Julia G. Mannheim, Laura Kuebler, Sabina Marciano, Mario Amend, Christoph Parl, Hanna Napieczyńska, Florian M. Maier, Salvador Castaneda Vega, Bernd Jürgen Pichler · 2019 · Molecular Imaging and Biology
  65. An intrinsically disordered region controlling condensation of a circadian clock component and rhythmic transcription in the liver
    Kun Zhu, Isaac J. Celwyn, Dongyin Guan, Xiao Yang, Xiang Wang, Wenxiang Hu, Chunjie Jiang, Lan Cheng, Rafael C. Casellas, Mitchell A. Lazar · 2023 · Molecular Cell
  66. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research
    Shuai Zhen, Xu Li · 2018 · Human Gene Therapy
  67. Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRa
    Cia‐Hin Lau, Jonathan Weng‐Thim Ho, Pik Kwan Lo, Chung Tin · 2019 · Molecular Therapy — Nucleic Acids
  68. New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape
    Maja van Hees, Sofie Slott, Anders Højgaard Hansen, Heon Seok Kim, Hanlee P. Ji, Kira Astakhova · 2021 · Molecular Therapy
  69. Remyelination protects neurons from DLK-mediated neurodegeneration
    Greg J. Duncan, Sam D. Ingram, Katie Emberley, Josephine E. Hill, C. Cordano, A. Abdelhak, Michael McCane, Jennifer E Jenks, Nora Jabassini, Kirtana Ananth et al. · 2023 · bioRxiv
  70. Virus stamping for targeted single-cell infection in vitro and in vivo
    Rajib Schubert, Stuart Trenholm, Kamill Bálint, Georg Kosche, Cameron S. Cowan, Manuel Alexander Mohr, Martin Munz, David Martínez-Martín, Gotthold Fläschner, Richard Newton et al. · 2017 · Nature Biotechnology
  71. Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
    Wenhan Yu, Zhijian Wu · 2020 · Advanced Drug Delivery Reviews
  72. Genetically modified large animal models for investigating neurodegenerative diseases
    Yang, Weili, Chen, Xiusheng, Li, Shihua, Li, Xiao-Jiang · 2021 · Cell & Bioscience
  73. Nanoscale bio-platforms for living cell interrogation: current status and future perspectives
    Lingqian Chang, Jiaming Hu, Feng Chen, Zhou Chen, Junfeng Shi, Zhaogang Yang, Yiwen Li, Ly James Lee · 2015 · Nanoscale
  74. Genome editing and the next generation of antiviral therapy
    Daniel Stone, Nixon Niyonzima, Keith R. Jerome · 2016 · Human Genetics
  75. Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer
    Jingyue Yan, Diana D. Kang, Gillian Turnbull, Yizhou Dong · 2021 · Advanced Drug Delivery Reviews
  76. Genome Editing of Monogenic Neuromuscular Diseases
    Chengzu Long, Leonela Amoasii, Rhonda Bassel‐Duby, Eric N. Olson · 2016 · JAMA Neurology
  77. CRISPR/Cas9 Targets Chicken Embryonic Somatic Cells In Vitro and In Vivo and generates Phenotypic Abnormalities
    Kwaku Dad Abu-Bonsrah, Dongcheng Zhang, Donald F. Newgreen · 2016 · Scientific Reports
  78. Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis
    Gunjan Arora, Richa Misra, Andaleeb Sajid · 2017 · Current Topics in Medicinal Chemistry
  79. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups
    Minjung Song · 2017 · Biotechnology Progress
  80. AAV-CRISPR/Cas9–Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro
    Wenyi Wu, Yajian Duan, Gaoen Ma, Guohong Zhou, Cindy Park‐Windhol, Patrìcia A. D'Amore, Hetian Lei · 2017 · Investigative Ophthalmology & Visual Science
  81. Transverse sinus injections drive robust whole-brain expression of transgenes
    Ali S. Hamodi, Aude Martinez Sabino, N. Dalton Fitzgerald, Dionysia Moschou, Michael C. Crair · 2020 · eLife
  82. Light-responsive charge-reversal nanovector for high-efficiency in vivo CRISPR/Cas9 gene editing with controllable location and time
    Yunxia Wu, Judun Zheng, Qin Zeng, Tao Zhang, Da Xing · 2020 · Nano Research
  83. Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice
    Sam Hana, Michael A. Peterson, Helen McLaughlin, Eric Marshall, Attila J. Fabian, Olivia P. McKissick, Kathryn Koszka, Galina Marsh, Michael Craft, Shanqin Xu et al. · 2021 · Gene Therapy
  84. Using CRISPR/Cas to study gene function and model disease in vivo
    Darjus Felix Tschaharganeh, Scott W. Lowe, Ralph J. Garippa, Geulah Livshits · 2016 · FEBS Journal
  85. A Retroviral CRISPR-Cas9 System for Cellular Autism-Associated Phenotype Discovery in Developing Neurons
    Michael R. Williams, Catherine J. Fricano-Kugler, Stephanie A. Getz, Patrick D. Skelton, Jeonghoon Lee, Christian P. Rizzuto, Joseph S. Geller, Meijie Li, Bryan W. Luikart · 2016 · Scientific Reports
  86. CRISPR/Cas9-mediated correction of human genetic disease
    Ke Men, Xingmei Duan, Zhiyao He, Yang Yang, Shaohua Yao, Yuquan Wei · 2017 · Science China Life Sciences
  87. Personalised genome editing – The future for corneal dystrophies
    Tara Moore, Kathleen A. Christie, John Marshall, M. Andrew Nesbit · 2018 · Progress in Retinal and Eye Research
  88. Delta glutamate receptor conductance drives excitation of mouse dorsal raphe neurons
    Stephanie C. Gantz, Khaled Moussawi, Holly Sue Hake · 2020 · eLife
  89. A line attractor encoding a persistent internal state requires neuropeptide signaling
    George Mountoufaris, Aditya Nair, Bin Yang, Dong-Wook Kim, Amit Vinograd, Samuel Kim, Scott W. Linderman, David J. Anderson · 2024 · Cell
  90. MECP2 and the biology of MECP2 duplication syndrome
    Santosh R. D’Mello · 2021 · Journal of Neurochemistry
  91. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors
    Zachary J. Tickner, Michael Farzan · 2021 · Pharmaceuticals
  92. Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in human cells using compact expression cassettes
    Eli J. Fine, Caleb M. Appleton, Douglas E. White, Matthew T. Brown, Harshavardhan Deshmukh, Melissa Lambeth Kemp, Gang Bao · 2015 · Scientific Reports
  93. The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD
    Wang, Jing-Zhang, Wu, Peng, Shi, Zhi-Min, Xu, Yan-Li, Liu, Zhi-Jun · 2017 · Brain and Development
  94. Low-dose AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in neonatal hemophilia B mice with subtle antibody response
    Xijing He, Zhenjie Zhang, Junyi Xue, Yaofeng Wang, Siqi Zhang, Junkang Wei, Chenzi Zhang, Jue Wang, Brian Anugerah Urip, Chun Christopher Ngan et al. · 2022 · Nature Communications
  95. CRISPR‐Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies
    Wanshun Wen, Zhi‐Min Yuan, Shijie Ma, Xu Jiang, Dongtang Yuan · 2015 · International Journal of Cancer
  96. Epigenetic Mistakes in Neurodevelopmental Disorders
    Giuseppina Mastrototaro, Mattia Zaghi, Alessandro Sessa · 2017 · Journal of Molecular Neuroscience
  97. Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects
    Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya · 2024 · Functional & Integrative Genomics
  98. A Single H1 Promoter Can Drive Both Guide RNA and Endonuclease Expression in the CRISPR-Cas9 System
    Zongliang Gao, Elena Herrera-Carrillo, Ben Berkhout · 2018 · Molecular Therapy — Nucleic Acids
  99. Heat-Triggered Remote Control of CRISPR-dCas9 for Tunable Transcriptional Modulation
    Lena Gamboa, Erick V. Phung, Haoxin Li, Jared P. Meyers, Anna C. Hart, Ian C. Miller, Gabriel A. Kwong · 2020 · ACS Chemical Biology
  100. Elevated levels of FMRP-target MAP1B impair human and mouse neuronal development and mouse social behaviors via autophagy pathway
    Yu Guo, Minjie Shen, Qiping Dong, Natasha M. Méndez-Albelo, Sabrina X. Huang, Carissa L. Sirois, Jonathan Le, Meng Li, Ezra D. Jarzembowski, Keegan A. Schoeller et al. · 2023 · Nature Communications